The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
The latest from pharma companies on potential COVID-19 treatments with news from Pfizer, Merck & Co., Sanofi, AstraZeneca, Theravance and Inovio.
News from Pfizer, Merck & Co., Sanofi, and AstraZeneca
Pfizer, BioNTech Complete Dosing in...
A roundup of developments from China (Seneca Biopharma), India (Biocon), Japan (Astellas), Switzerland (Novartis), and the US (Amneal and Merck KGaA).
China
Seneca Biopharma Completes Stem-Cell Mfg Facility in China Seneca Biopharma, a Rockville,...
The European Medicines Agency has issued guidance on managing clinical trials impacted by the COVID-19 pandemic, and the FDA issued information for generic-drug manufacturers on conducting bioequivalence studies affected the by COVID-19...
Gilead Sciences reported this week (April 29, 2020) promising results from a Phase III clinical trial evaluating its investigational antiviral drug, remdesivir, as a treatment for hospitalized patients with severe COVID-19.
The study evaluated...
Takeda and ProThera Biologics, a Providence, Rhode Island-based development company, have entered into a global licensing agreement to develop a plasma-derived inter-alpha inhibitor proteins (IAIP) therapy for the treatment of acute inflammatory...
Takeda has agreed to divest to Orifarm Group, an Odense, Denmark-based generic-drug company, a portfolio of approximately 110 select over-the-counter (OTC) and prescription pharmaceutical products sold in Europe and two manufacturing sites in...
The US Food and Drug Administration (FDA) has issued a drug-safety communication for hydroxychloroquine and chloroquine, two drugs being evaluated as potential treatments against the novel coronavirus (COVID-19).
“The FDA is aware of reports of...
The US Food and Drug Administration (FDA) has provided an update as to its drug-review practices and timelines as specified through its user-fee programs in the wake of the novel coronavirus (COVID-19) outbreak.
With respect to drugs, the FDA has...
The latest contributions from Teva, Bayer, and Merck & Co., in funding and donations supporting relief efforts against COVID-19.
Teva Donates Potential COVID-19 Drugs Hydroxychloroquine and AzithromycinTeva Pharmaceutical Industries has...
Gilead Sciences, its subsidiary, Kite, and oNKo-innate, a Melbourne, Australia-based discovery-stage company for immuno-oncology drug development, have entered into a three-year cancer immunotherapy research collaboration to support discovery and...
Andrew Witty, former chief executive officer (CEO) of GlaxoSmithKline, and current President of UnitedHealth Group, a health insurer, and CEO of Optum, UnitedHealth Group’s health services company, has been asked to co-lead an effort organized by...
Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development...
European Union (EU) authorities have set alternative measures for inspections of drug-manufacturing facilities in the EU during the novel coronavirus (COVID-19) outbreak and have launched a new system for reporting shortages of COVID-19-related...
The latest from pharma companies on potential COVID-19 treatments with news from Novartis, Pfizer, AstraZeneca, Biogen, Bayer, Alexion, Fujifilm, and Celltrion.
News from Novartis, Pfizer, AstraZeneca, Biogen and Bayer
Novartis Sponsors Phase III...
Roche develops antibody test for COVID-19, and Sanofi partners for smartphone-based self-test for COVID-19. FDA provides overall COVID testing update.
Roche Develops Serology Test to Detect COVID-19 AntibodiesRoche has initiated the development...
